U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559474) titled 'A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment' on April 24.
Brief Summary: This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Hepatic Insufficiency
Liver Diseases
Intervention:
DRUG: INCB123667
single dose administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Disclaimer: Curated by HT Syndication....